Ocular Therapeutix, Inc.
XNAS:OCUL
11.85
$12.09 - 326.00
$11.65 - 326.00
$11.61
$12.06
$11.97
$12.15
13.85
5.79
1980388
3000483.9
186811753.28
Chart
TendieTensor AI Analysis
Company
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Fundamentals
274
-8.150000
7.933500
-0.38
100
BBG001J1BZV0
BBG001V0FT93
174.00M
213.05M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own OCUL. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.